These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 164871)

  • 1. The dopamine vascular receptor.
    Goldberg LI
    Biochem Pharmacol; 1975 Mar; 24(6):651-3. PubMed ID: 164871
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dopamine on coronary vascular resistance and myocardial function.
    Nayler WG; McInnes I; Stone J; Carson V; Lowe TE
    Cardiovasc Res; 1971 Apr; 5(2):161-8. PubMed ID: 5579520
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of dopamine on the conductance of perfused vascular beds of the chloralosed cat.
    Hamilton TC
    Br J Pharmacol; 1972 Mar; 44(3):442-50. PubMed ID: 4402742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practolol blockade of cardiac but not vascular or uterine beta-adrenergic receptors in the anesthetized cat.
    Levy B
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):143-6. PubMed ID: 4147749
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of dopamine and norepinephrine on myocardial function and metabolism during experimental cardiogenic shock.
    Bagwell EE; Daniell HB
    J Pharmacol Exp Ther; 1970 Jun; 173(2):357-63. PubMed ID: 5434019
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary and myocardial effects of dopamine in the conscious dog: parasympatholytic augmentation of pressor and inotropic actions.
    Vatner SF; Millard RW; Higgins CB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):280-95. PubMed ID: 4147854
    [No Abstract]   [Full Text] [Related]  

  • 7. Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.
    Kohli JD; Weder AB; Goldberg LI; Ginos JZ
    J Pharmacol Exp Ther; 1980 May; 213(2):370-4. PubMed ID: 7365696
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary and systemic hemodynamic effects of dopamine in the awake dog.
    Cobb FR; McHale PA; Bache RJ; Greenfield JC
    Am J Physiol; 1972 Jun; 222(6):1355-60. PubMed ID: 5030192
    [No Abstract]   [Full Text] [Related]  

  • 9. Relaxant effects of dopamine and isoprenaline on canine isolated coronary arteries--relationship to cyclic AMP production [proceedings].
    Al-Jeboory A; Marshall RJ
    Br J Pharmacol; 1978 Mar; 62(3):373P-374P. PubMed ID: 205291
    [No Abstract]   [Full Text] [Related]  

  • 10. Histamine modulates dopamine-induced contraction in canine tracheal smooth muscle.
    Chen CJ; Shue CH
    Chin J Physiol; 1990; 33(3):279-89. PubMed ID: 1980100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic receptors.
    Nickerson M
    Circ Res; 1973 May; 32():Suppl 1:53-60. PubMed ID: 4145855
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences between the effects of dopamine and apomorphine on rat aortic strips.
    Cohen ML; Berkowitz BA
    Eur J Pharmacol; 1975 Nov; 34(1):49-58. PubMed ID: 187435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of relationship between myocardial cyclic AMP concentrations and inotropic effects of sympathomimetic amines.
    Benfey BG
    Br J Pharmacol; 1971 Dec; 43(4):757-63. PubMed ID: 4339883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of intracoronary prostaglandin E 1 on myocardial lipolysis.
    Glaviano VV; Masters T
    Am J Physiol; 1971 May; 220(5):1187-93. PubMed ID: 4324937
    [No Abstract]   [Full Text] [Related]  

  • 15. The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.
    Osborne MW; Wenger JJ; Willems W
    J Pharmacol Exp Ther; 1971 Sep; 178(3):517-28. PubMed ID: 5571901
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of catecholamines on the smooth muscle of the female reproductive tract.
    Marshall JM
    Annu Rev Pharmacol; 1973; 13():19-32. PubMed ID: 4145966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular effect of a cardiac glycoside, proscillaridin A].
    Kubota M; Kudo K; Suzuki N; Yoshida T; Yoshikawa Y
    Masui; 1971 Sep; 20(10):924-5. PubMed ID: 5166790
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of propranolol on the peripheral vascular bed.
    Nakano J; Kusakari T
    Nature; 1966 Feb; 209(5026):923-4. PubMed ID: 5922798
    [No Abstract]   [Full Text] [Related]  

  • 19. The mechanism of hypotensive action of N-(2-(2-methoxyphenoxy) ethyl)-3-(2, 5-dimethoxyphenoxy) propylamine hydrochloride.
    Bapna JS; Dandiya PC
    Indian J Physiol Pharmacol; 1969 Jan; 13(1):47-51. PubMed ID: 4390897
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of propranolol and ICI 50,172 on the cardiovascular actions of catecholamines as modified by ergotamine.
    Osswald W; Guimarães S; Garrett J
    J Pharmacol Exp Ther; 1970 Aug; 174(2):315-22. PubMed ID: 5451366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.